10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10x Genomics employed 584 workers worldwide at the end of 2019, ... primarily so it can tap what it sees as a world-class technical talent pool in the Bay Area. Plus, ...

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. Find out why TXG is poised for sustained growth.

Life-sciences technology startup 10x Genomics Inc. said its initial public offering was priced above the high end of the expected range, giving it a valuation topping $3.6 billion.